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Abstract
Objectives Accurate staging of oesophageal cancer (OC) is
vital. Bibliometric analysis highlights key topics and publica-
tions that have shaped understanding of a subject. The 100
most cited articles investigating radiological staging of OC are
identified.
Methods The Thomas Reuters Web of Science database with
search terms including BCT, PET, EUS, oesophageal and
gastro-oesophageal junction cancer^ was used to identify all
English language, full-script articles. The 100 most cited arti-
cles were further analysed by topic, journal, author, year and
institution.
Results A total of 5,500 eligible papers were returned. The
most cited paper was Flamen et al. (n= 306), investigating
the utility of positron emission tomography (PET) for the
staging of patients with potentially operable OC. The most
common research topic was accuracy of staging investigations
(n=63). The article with the highest citation rate (38.00), de-
fined as the number of citations divided by the number of
complete years published, was Tixier et al. investigating
PET texture analysis to predict treatment response to neo-
adjuvant chemo-radiotherapy, cited 114 times since publica-
tion in 2011.
Conclusion This bibliometric analysis has identified key pub-
lications regarded as important in radiological OC staging.
Articles with the highest citation rates all investigated PET
imaging, suggesting this modality could be the focus of future
research.
Main Messages
• This study identifies key articles that investigate radiological
staging of oesophageal cancer.
• The most common topic was accuracy of staging
investigations.
• The article with the highest citation rate investigated the use
of texture analysis in PET images.
Keywords Bibliometric analysis . Oesophageal cancer .
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Introduction
Bibliometric analysis assesses the number of times that an
article is cited in the literature, and in which particular journal.
A citation is received when an article references another peer-
reviewed publication. An article that is felt to have greater
importance and higher impact by the scientific community is
more likely to be cited and therefore may be more influential
on current healthcare practice. Articles and journals can be
ranked based on the number of citations they receive.
Bibliometric analysis also reveals topics of current interest,
identifies potential novel techniques and shows historical de-
velopments in that subject [1]. Medical researchers have used
bibliometric analysis to identify the most influential papers in
their clinical specialties, including orthopaedic surgery [2] and
oncology [3].
Worldwide, the prognosis of oesophageal cancer, including
gastro-oesophageal junction cancer (OC), is poor. Overall 5-
year survival in the UK is approximately 13% [4]. As a part of
the diagnostic pathway, patients undergo a variety of staging
investigations to assess the extent of disease. Radiological
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staging is performed to further inform management decisions
by the multi-disciplinary team (MDT). Accurate radiological
staging is vital to ensure the most appropriate treatment is
selected. Currently, OC is staged according to the
International Union Against Cancer (UICC) Tumour Node
Metastasis (TNM) 7th edition [5].
In the UK, patients with OC are initially staged with CT of
the thorax and abdomen to exclude irresectable disease or
distant metastases. If the patient is deemed suitable for radical
treatment, either in the form of definitive chemo-radiotherapy
(dCRT) or surgery (± neo-adjuvant therapy), positron emis-
sion tomography combined with computed tomography
(PET/CT) and endoscopic ultrasound (EUS) are performed
for a more detailed assessment of disease stage [6].
This bibliometric analysis of OC staging investigations
aims to identify key research that has influenced staging
methods, the institutions leading this research, studies that
may change staging methods in the future and imaging mo-
dalities being focused upon.
Materials and methods
The Thomas Reuters Web of Science citation indexing data-
base was used to perform the search. The following search
terms were used in order to capture the variety of imaging
modalities and the different nomenclature of tumours:
(oesophag* AND (neoplas* OR cancer* OR carcin* OR
tumo* OR malig*)) OR (esophag* AND (neoplas* OR can-
cer* OR carcin* OR tumo* OR malig*)) OR (gastro-oesoph-
ageal junction AND (neoplas* OR cancer* OR carcin* OR
tumo* OR malig*)) OR (oesophago-gastric junction AND
(neoplas* OR cancer* OR carcin* OR tumo* OR malig*)
AND (computed tomography OR CT OR CAT) OR (positron
emission tomography OR PET OR F18 OR FDG OR
fluorodeoxyglucose) OR (endoscopic ultrasonography OR
endoscopic ultrasound OR endosonographic OR EUS) OR
(magnetic resonance imaging OR MRI or diffusion weight*
OR DWI) AND (stag* OR TNM OR lymph node OR
metasta*). The search was performed on 18 September 2015.
All databases within the Thomas Reuters Web of Science
were searched. The results were filtered to include only full
script articles written in the English language, throughout all
available years. The results were sorted by number of cita-
tions, with the article with most citations analysed first. The
method was developed by Paladugu et al. [7].
The title and abstract of the returned articles were manually
assessed to ensure that their relevance and content were in
keeping with this field. The inclusion criterion was that the
article investigated the use of a single or combination of ra-
diological modalities in patients with OC. This criterion was
pre-specified and defined prior to data collection.
Articles were excluded from the list if the content was not
relevant to radiological OC staging. The 100 most cited arti-
cles were identified and further analysed.
The articles were further evaluated for the publishing jour-
nal, names of the first and senior author, the institution and
department to which the first author was affiliated, the country
of origin, year of publication, the radiological investigation(s)
being studied, the topic of the article and the number of cita-
tions according to Web of Science. Rank within the top 100
articles was also recorded.
Articles have the opportunity to accrue more citations if
they have been published for longer. To adjust for this, a cita-
tion rate was calculated, defined as the number of citations
divided by the number of complete years published. A list of
the ten articles with the highest citation rates is provided.
In addition, the individual and 5-year impact factors in
2014 were recorded for the publishing journal. The overall
median 2014 and 5-year impact factor for all journals was
calculated.
Results
TheWeb of Science search returned 5,500 full articles, written
in English language. The 100 most cited articles are listed in
Table 1 [8–107].
The article with the highest number of citations (n=306)
was Flamen et al. [8], entitled ‘Utility of positron emission
tomography for the staging of patients with potentially opera-
ble oesophageal carcinoma’. The article ranked 100 in the list
was Wu et al. [107], entitled ‘Preoperative TN staging of oe-
sophageal cancer: comparison of miniprobe ultrasound, spiral
CT and MRI’, with 46 citations.
The oldest article was published in 1979 by Daffner et al.
[71] ‘CT of the Oesophagus. 2. Carcinoma’. Tixier et al. [47]
published the most recent paper in the list in 2011, entitled
‘Intratumor Heterogeneity Characterized by Textural Features
on Baseline F-18-FDG PET Images Predicts Response to
Concomitant Radiochemotherapy in Esophageal Cancer’,
which has been cited 114 times.
The journal with the highest number of published articles
was Gastrointestinal Endoscopy (Table 2). Fourteen articles
were published with a total of 1675 citations [11, 16, 34, 38,
48, 59, 62, 63, 66, 76, 80, 82, 83, 85]. The 2014 impact factor
of the Gastrointestinal Endoscopy was 5.369, with 5-year im-
pact factor 5.225. The journal with the highest impact factor
was the Journal of Clinical Oncology (JCO), which had a total
of 1,258 citations [8, 12, 15, 18, 23, 70]. Five of these six
articles were investigating PET imaging. The 2014 impact
factor of JCO was 18.428, with 5-year impact factor 16.996.
Overall, the median 2014 impact factor of the journals was
5.238 and median 5-year impact factor was 5.225.
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Table 1 The 100 most cited articles in radiological staging of
oesophageal and junctional cancer
Rank Number of Citations First author
1 306 Flamen P [8]
2 294 Tio TL [9]
3 290 Kinkel K [10]
4 273 Catalano MF [11]
5 271 Wieder HA [12]
6 261 Botet JF [13]
7 242 Skinner DB [14]
8 229 Ott K [15]
9 221 Bhutani MS [16]
10 201 Flamen P [17]
11 193 Downey RJ [18]
12 192 Flanagan FL [19]
13 189 Picus D [20]
14 184 Rosch T [21]
15 183 Kelly S [22]
16 168 van Westreenen HL [23]
17 165 May A [24]
18 164 Lerut T [25]
19 160 Kato H [26]
20 159 Block MI [27]
20 159 Swisher SG [28]
22 157 Swisher SG [29]
23 150 Luketich JD [30]
24 146 Rice TW [31]
24 146 Vilgrain V [32]
26 145 van Vliet EPM [33]
27 143 Rosch T [34]
28 137 Ziegler K [35]
29 136 Kole AC [36]
30 135 Luketich JD [37]
31 133 Buskens CJ [38]
32 132 Watt I [39]
33 130 Moss AA [40]
34 123 Zuccaro G [41]
35 122 Grimm H [42]
36 121 Vazquez-Sequeiros E [43]
37 116 Yoon YC [44]
38 115 Tio TL [45]
39 114 Cerfolio RJ [46]
39 114 Tixier F [47]
41 113 Vazquez-Sequeiros E [48]
42 112 Dittler HJ [49]
43 111 Rasanen JV [50]
44 108 Quint LE [51]
45 107 Reed CE [52]
46 105 Choi JY [53]
46 105 Rankin SC [54]
46 105 Thompson WM [55]
Table 1 (continued)
Rank Number of Citations First author
46 105 Wallace MB [56]
50 104 Quint LE [57]
51 103 Kato H [58]
51 103 Larghi A [59]
53 102 Takashima S [60]
54 100 van Westreenen HL [61]
55 98 Eloubeidi MA [62]
55 98 Hasegawa N [63]
57 96 Levine EA [64]
57 96 Rice TW [65]
59 92 Isenberg G [66]
59 92 Leong T [67]
59 92 Puli SR [68]
62 91 Flamen P [69]
62 91 Lightdale CJ [70]
64 89 Daffner RH [71]
64 89 Kim K [72]
64 89 Meltzer CC [73]
64 89 Vrieze O [74]
68 88 Jones DR [75]
69 86 Chak A [76]
70 84 Hyun SH [77]
70 84 Quint LE [78]
72 83 Murata Y [79]
73 82 Hiele M [80]
74 80 Wakelin SJ [81]
75 79 Scotiniotis IA [82]
76 78 Fockens P [83]
77 76 Beseth BD [84]
77 76 Catalano MF [85]
77 76 Giovannini M [86]
80 75 Rice TW [87]
81 74 Heeren PAM [88]
81 74 Rizk N [89]
83 72 Kostakoglu L [90]
83 72 Moureau-Zabotto L [91]
85 70 Pech O [92]
86 69 Choi JY [93]
86 69 Lehr L [94]
86 69 Lightdale CJ [95]
89 68 Kobori D [96]
89 68 Luketich JD [97]
91 67 Lowe VJ [98]
92 62 Song SY [99]
92 62 Yuan S [100]
94 61 Bar-Shalom R [101]
94 61 McAteer D [102]
94 61 van Westreenen HL [103]
97 60 Eloubeidi MA [104]
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Twenty-nine of the 100 articles were published in a radiol-
ogy-related journal, including nuclear medicine and radiation
oncology journals. Thirty-five of the first authors were affili-
ated to a radiology, nuclear medicine or radiation oncology
department, according to the Thomas Reuters Web of Science
citation indexing database. Three radiology-related journals,
with 5-year impact factor >5.00, published 16 articles in the
top 100. These were Radiology (5-year impact factor 7.259;
n = 6), Journal of Nuclear Medicine (5-year impact factor
6.280; n=8) and European Journal of Nuclear Medicine and
Molecular Imaging (5-year impact factor 5.090; n=1).
Researchers from the USA published the greatest number
of articles in the 100most cited (n=47) [11, 13, 14, 16, 18–20,
27–31, 37, 40, 41, 43, 46, 48, 51, 52, 55–57, 59, 62, 64–66,
68, 70, 71, 73, 75, 76, 78, 82, 84, 85, 87, 89, 90, 95, 97, 98,
104–106], jointly followed by Germany [12, 15, 21, 24, 34,
35, 42, 49, 92, 94] and The Netherlands [9, 23, 33, 36, 38, 45,
61, 83, 88, 103] (n = 10, each) (Table 3). The Technical
University of Munich, Germany, was the institution with the
joint highest number of publications in the 100 Most Cited
(n=6) and the highest number of citations (1,008) [12, 15, 21,
34, 49, 94]. The University Hospital Gasthuisberg, Leuven,
Belgium, also had 6 published articles, with a total of 933
citations [8, 17, 25, 69, 74, 80]. The most cited article was
from this institution [8] and written byDr Patrick Flamen (first
author) with Prof. Luc Mortelmans as senior author. Dr
Flamen has 3 first author articles in the 100 most cited [8,
17, 69] and a total of 598 citations. Prof. Mortelmans has 4
articles published as senior author [8, 17, 25, 69] and a total of
762 citations.
The most common researched topic was the accuracy of
radiological staging investigations (n=63) (Table 4). Several
of the study themes overlapped but accuracy of staging was
commonly compared between different modalities (n=29).
The investigation of lymph node metastases (n=15) and ra-
diological response to treatment (n=14) were also commonly
cited topics.
EUS was the most common modality investigated (n=51),
with PET/CT (n=48) and CT (n=46) following. The combi-
nation of CT, EUS and PET/CT was commonly investigated
Table 1 (continued)
Rank Number of Citations First author
97 60 Konski A [105]
99 59 Meyers BF [106]
100 46 Wu LF [107]
Table 2 Journals with ≥2 articles in 100 most cited
Journal Number of articles 2014 Impact factor 5-Year impact factor Total number of citations
Gastrointestinal Endoscopy 14 5.369 5.225 1,675
Annals of Thoracic Surgery 9 3.849 4.104 1,038
Journal of Nuclear Medicine 8 6.16 6.280 657
Cancer 7 5.238 5.517 830
American Journal of Roentgenology 6 2.731 3.302 764
Journal of Clinical Oncology 6 18.428 16.966 1,258
Radiology 6 6.867 7.259 1,044
Endoscopy 5 5.053 4.855 494
Journal of Thoracic and Cardiovascular Surgery 5 4.168 4.068 428
Annals of Surgery 3 8.327 8.844 502
Gut 3 14.66 12.553 485
International Journal of Radiation Oncology Biology Physics 3 4.258 4.359 194
American Journal of Gastroenterology 2 10.755 9.145 193
Annals of Surgical Oncology 2 3.93 4.532 195
British Journal of Cancer 2 4.836 5.305 281
Gastroenterology 2 16.716 13.811 415
Radiotherapy and Oncology 2 4.363 4.502 181
World Journal of Gastroenterology 2 2.369 2.671 138
Table 3 Number of articles per country of origin in 100 most cited
Country Total number of articles
USA 47
Germany 10
The Netherlands 10
Belgium 6
Japan 6
South Korea 6
UK 5
France 4
China 2
Australia 1
Finland 1
Israel 1
Switzerland 1
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together, which is the recommended staging pathway for po-
tentially curable disease in the UK (n=11) [8, 25, 28, 31, 50,
53, 88, 98, 105]. MRI (n=5), bone scintigraphy (n=2), PET
alone (n=1), EUS-FNA (n=1), US (n=1) and laparoscopic
US (n=1) were also cited.
The article with the highest citation rate (38.00) was Tixier
et al. [47], published in 2011 and investigated texture analysis
in OC. The ten articles with the highest citation rates were
published between 2002 and 2011 and all involved investiga-
tion of PET images (Table 5). Four of the articles investigated
treatment response [12, 15, 18, 47]. An international collabo-
ration collecting data that informed the International Union
Against Cancer (UICC) Tumour Node and Metastasis
(TNM) 7th edition [31] had the second highest citation rate
(36.50). Five of the ten articles with the highest citation rates
were published in the Journal of Clinical Oncology, which had
the highest impact factor (5-year 16.971).
Discussion
OC is the eighth most common malignancy worldwide,
resulting in around 400,000 deaths per annum [108]. This
study demonstrates that accuracy of staging was the most
frequently studied topic (n=63) (Table 4). Accurate staging
investigations are vital to inform appropriate treatment deci-
sions, providing the best chance of survival for the patient
whilst minimising harm from over- or under-treatment. The
most cited article was Flamen et al. [8], which investigated the
use of PET in potentially operable OC.
The OC staging pathway is complex, utilising various mo-
dalities with different strengths and weaknesses. PET/CT is
superior to CT for detection of distant metastases and influ-
ences the change of MDT management decisions in up to
38 % of patients [109], whereas EUS is superior to CT for
T-staging [110]. Comparison of techniques allows a modality
to be tested against the perceived Bgold-standard^ staging in-
vestigation. This may reflect the desire for a simplified staging
pathway with fewer investigations or the desire to increase
evidence and awareness of a particular modality, thus intro-
ducing potential publication bias.
Influential articles are more likely to be cited by the scien-
tific and clinical community. These citations form the basis of
a journal’s impact factor. The impact factor quantifies the av-
erage number of citations per manuscript publishedwithin that
journal during a specific time period. Therefore, journals with
a higher impact factor are recognised as being of higher qual-
ity and more likely to contain influential articles.
Radiological OC staging appeals to specialist radiologists
and other members of the upper gastro-intestinal (GI) cancer
MDT, and its clinical impact is great. The overall median 2014
and 5-year impact factors were 5.238 and 5.225, respectively,
demonstrating that this field of research, often producing nov-
el results, in a specific cancer population is not likely to be
published in high-impact journals. The Journal of Clinical
Oncology (JCO) had the highest 5-year impact factor
(16.971) of articles in the 100 most cited.
In total, only 29 of the 100 most cited articles were pub-
lished in radiology-related journals. This could represent the
desire to achieve publication in a high-impact journal. The
majority of radiology-related journals have impact factors
<5.00. Only 16 % of the top 100 articles were published in
radiology-related journals with a 5-year impact factor >5.00
(Radiology, Journal of Nuclear Medicine and European
Journal of Nuclear Medicine and Molecular Imaging). It
may also reflect a lack of research conducted by radiologists,
which is supported by evidence from a National Cancer
Research Institute (NCRI) survey in 2012, which commented
upon the lack of academic radiologists [111].
Many of the first authors (n=65) are not affiliated to radi-
ology departments, according to Thomas Reuters Web of
Science citation indexing database. It is possible the authors
work closely with a radiologist as part of the specialist Upper
GI cancer MDT or have a clinical radiologist as a
named co-author.
EUS was the most commonly investigated modality over-
all. This may be a reflection of the current reliance and impor-
tance of EUS for Tand N staging, considered the current Bgold
standard^ [110].
Despite EUS being the most frequently investigated mo-
dality, the ten articles with the highest citation rates all inves-
tigated functional PET imaging. The CT component of the
PET/CT examinations provided attenuation correction for
Table 4 Most frequently cited topics of investigation (numbers do not
add up to 100 as there are different combinations of topics in the articles)
Topic Number of articles
Accuracy of staging 63
Comparison of imaging modalities 29
Lymph node metastases 15
Treatment response 14
Review of staging 9
Imaging features of malignancy 9
Prognosis 7
Distant metastases 5
Treatment planning 4
Early cancer 3
Cost-effectiveness 1
Restaging 1
Staging recurrent cancer 1
Correlation with tumour markers 1
Synchronous tumours 1
Texture analysis 1
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PET data. Many PET/CT topics of research are relatively
novel and have been described in other types of cancer.
One of these topics, texture analysis, is the subject of the
article with the highest citation rate [47]. Novel subjects
are less likely to be published in high-impact journals, but
may well be considered influential and provide the catalyst
for future research.
Four of the PET/CT articles with the highest citation rates
[12, 15, 18, 47] investigated its use in assessing treatment
response. There is significant interest in the capability of met-
abolic imaging to assess for early treatment response, but
these techniques have not been standardised for use outside
of clinical research studies [112]. PET/CT scanning is expen-
sive, and costly research could potentially only produce mar-
ginal long-term benefits for patients. The paradox of
healthcare is that innovation increases expense, rather than
producing more cost-effective and efficient processes, as is
the case in industry [113]. These articles however are likely
to be highly influential in forthcoming years, as the use of
PET/CT increases in cancer imaging.
This bibliometric analysis has a number of limitations.
Citation rates can be misleading because of various biases,
e.g. institutional, language or self-citation bias. Older articles
tend to accrue more citations compared to newer research. We
attempted to adjust for this by calculating a citation rate, which
may provide information regarding the importance and poten-
tial influence that the research has. This in itself has limitations
as the likelihood of citation rises with increasing numbers of
published articles in peer-reviewed journals. Only articles
written in English were included, which may have excluded
some frequently cited research in other languages. Also, this
study concentrated on radiological staging rather than other
techniques such as endoscopy and laparoscopy.
The expanding volume of published literature has in-
creased significantly over the past few decades. Between
1978 to 1985 and 1994 to 2001, the annual number of
Medline articles increased by 46 %, particularly in the area
of clinical research [114]. The annual rate of publication
growth in PubMed Medline was 5.6 % between 1997 and
2006, equating to a Bdoubling time^ of 13 years [115]. This
may explain the higher citation rate of PET/CT compared to
that of EUS, as PET/CT is a more recent innovation. Overall,
there are now more articles published per annum compared to
previous years. This would therefore potentially increase the
citation rate as a matter of course, not necessarily reflecting
higher importance.
Table 5 Ten articles with the highest citation rates
Rank Year Number of
citations
Citation rate First author Senior author Title Journal
1 2011 114 38.00 Tixier F [47] Visvikis D Intratumour heterogeneity characterized
by textural features on baseline 18
F-FDG PET images predicts response
to concomitant radiochemotherapy in
oesophageal cancer
Journal of Nuclear Medicine
2 2010 146 36.50 Rice TW [31] Blackstone EH Cancer of the Oesophagus and Esophagogastric
Junction Data-Driven Staging for the Seventh
Edition of the American Joint Committee on
Cancer/International Union Against Cancer
Cancer Staging Manual
Cancer
3 2006 229 28.63 Ott K [15] Siewert JR Metabolic imaging predicts response, survival,
and recurrence in adenocarcinomas of the
esophagogastric junction
Journal of Clinical Oncology
4 2004 271 27.10 Wieder HA [12] Weber WA Time course of tumour metabolic activity during
chemoradiotherapy of oesophageal squamous
cell carcinoma and response to treatment
Journal of Clinical Oncology
5 2002 290 24.17 Kinkel K [10] Thoeni RF Detection of hepatic metastases from cancers of
the gastrointestinal tract by using noninvasive
imaging methods (US, CT, MR imaging, PET):
A meta-analysis
Radiology
5 2008 145 24.17 van Vliet EPM [33] Siersema PD Staging investigations for oesophageal cancer:
a meta-analysis
British Journal of Cancer
7 2000 306 21.86 Flamen P [8] Mortelmans L Utility of positron emission tomography for the
staging of patients with potentially operable
oesophageal carcinoma
Journal of Clinical Oncology
8 2010 84 21.00 Hyun SH [77] Kim BT Prognostic value of metabolic tumour volume
measured by 18 F-fluorodeoxyglucose positron
emission tomography in patients with oesophageal
carcinoma
Annals of Surgical Oncology
9 2003 193 17.55 Downey RJ [18] Rusch V Whole body (18)FDG-PET and the response
of oesophageal cancer to induction therapy:
Results of a prospective trial
Journal of Clinical Oncology
10 2004 168 16.80 van Westreenen HL [23] Plukker JTM Systematic review of the staging performance
of 18 F-fluorodeoxyglucose positron emission
tomography in oesophageal cancer
Journal of Clinical Oncology
Insights Imaging
As expected, the older articles only described CT and per-
haps a review of the last 10 years of literature only may be
more reflective of contemporary staging practice. Another
limitation is that only the first and senior authors of the articles
were included in the current analysis. It is possible that these
authors contributed to other articles in this list, but would not
have been counted during analysis. These authors may there-
fore be under-represented in terms of published article num-
bers and have had a greater influence on current OC staging.
Of the 29 articles comparing imaging techniques or modal-
ities, 17 studies correlated imaging findings and histopatho-
logical diagnosis, widely regarded as the Bgold standard^.
Limitations exist in radiological studies that compare new
findings against a potentially inaccurate alternative imaging
test. In this current study, articles that did not compare against
pathological results included those investigating radiotherapy
planning techniques and the diagnosis of distant metastases. In
these studies, tissue was not necessarily sampled. There are
several reasons why pathological confirmation is not possible.
These include patients undergoing non-surgical management,
which is true of the majority of cases of OC, and in situations
where it would be unethical to obtain tissue purely for research
purposes, such as in patients with unequivocal distant
metastases.
There are further limitations of studies comparing imaging
findings to histopathological specimens. Comparison of pre-
treatment imaging characteristics in patients receiving neo-
adjuvant therapy prior to surgery can be inaccurate, as the
chemotherapy or radiotherapy may alter the morphology of
the tumour. In this situation, a direct comparison is often not
possible.
Conclusion
This bibliometric analysis describes the 100 most cited
articles in the field of radiological OC staging investi-
gations. Common topics of investigation include the ac-
curacy of staging, comparison of modalities, treatment
response and assessment of lymph nodes for metastases.
The majority of articles are published outside of
radiology-related journals, which may reflect the desire
for high-impact publications or perhaps a lack of radi-
ologists conducting imaging research. This study pro-
vides an understanding of research that has influenced
current OC staging and citation rates may suggest im-
portant topics for future research, particularly validation
studies of innovative techniques in larger patient
populations.
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